Welcome to the latest edition of Growth Opportunities in
the Pharmaceuticals & Biotechnology sector. This Newsletter covers the
pharmaceuticals, biotechnology, latest drugs, therapies and medications
markets.
Here at Frost & Sullivan, we believe that we have the
background, knowledge and application to partner with you and help you grow
strategically. This monthlyindustry Growth Opportunities Newsletter provides an
insight into the expertise we can offer in this specific arena. Our teams of
dedicated experts and consultants are on hand to advise
and support your company.
Our analysts regularly publish their articles on
pharmaceuticals-clinicaldiagnostics.frost.com.
The services mentioned in this Newsletter are delivered through our
Healthcare Growth Partnership Services program, which can help your company
reduce risk, capitalize on opportunities in the market, and achieve growth
greater than the industry average. To learn more about our comprehensive
offering, please
click here.
This communication is designed to be of value to you. If
you have any comments on how we can improve this, we would be very happy to
hear from you. Please e-mail your feedback toGrowthOpportunities@frost.com.
Growth Consulting in China
China
- Different, Difficult, and Unique
This article objectively
analyses the current state of the Chinese market. Further, it contains
information that will be relevant to companies that are looking for
opportunities to invest in China. Since 1998, Frost & Sullivan has been
helping the world's multinationals to enter and succeed in the Chinese
market. Today, a team of analysts is dedicated exclusively to this market,
helping us provide high quality research and unbiased growth advice to our
clients.
US
Leading Ophthalmic Diseases Markets
This Frost & Sullivan
research service entitled the US ophthalmic diseases markets addresses
patient dynamics and forecasts, product analysis, competitor and pipeline
analysis and market revenue forecasts for age-related macular degeneration,
chronic dry eye and ocular allergy. Click on the link below to learn more
about this study. Click
here to read more information Click
here to e-mail us for more information about this research service
Current
Clinical Applications and Trials of Stem Cell-based Therapies
This Frost & Sullivan research service is an analysis of the current
clinical applications and trials of stem cell-based therapies. It provides a
comprehensive and comparative analysis of the worldwide research initiatives
as well as regulatory frameworks in all major participant countries.
Further, it also covers most of the major global companies involved in stem
cell-based research and includes analysis of the potential stem cell-based
therapies market based on the forecast patient base for various diseases.
Click on the link below for further information. Click
here to read more information Click
here to e-mail us for more information about this research service
Upcoming Research
Approval
for Stem Cells to Begin Clinical Trails for Batten Disease
The Institutional Review Board of the Oregon Health & Science University
gave an approval to StemCells Inc. recently, to start a phase I clinical
trial of its human neural stem cell product (HuCNS-SC) to treat two forms
of Batten diseases, infantile and late-infantile neuronal ceroid
lipofuscinosis (NCL). This article examines the HuCNS-SC cell therapy and
the clinical trails that are being conducted currently. Click on the link
for more information on this interesting article.
Read More
Technical Research Snapshot
Developments
in Pharmacogenomics
This Frost & Sullivan research service offers insights into the
developments in pharmacogenomics. This study also examines technology
challenges, market drivers and restraints as well as assesses innovations
and opportunities. This research service helps market participants to know
about new innovations at key companies and research institutions that will
have an impact on the development of the industry. Click on the link for
more information. Click
here to read more information Click
here to e-mail us for more information about this research service
Recent Studies
Industry Forecasting Tools - Country Industry Forecast
Impact
of the Prices on the Brazilian Pharmaceutical and Drugs Industry
The Brazilian
pharmaceutical and drugs industry is ranked second largest in Latin America.
A major chunk of the production is domestic. The prices of pharmaceutical
drugs are controlled by Brazilian National Health Vigilance Agency (ANVISA)
and are extremely sensitive to macroeconomic factors, such as the
devaluation of the Brazilian currency that had an impact on the prices of
drugs. The generic drug market has been catching up and placing its toll on
the price of branded drugs. For more details on this industry, read the
research service on Brazil that analyses the latest political, economic and
policy changes that are perceived to impact its healthcare industry. Click
here to read more information Click
here to e-mail us for more information about this research service
Sales
Enablement: Not your Father's SFA
This e-Broadcast provides detailed information on the CRM growth
opportunities market. It is believed that sales personnel need help in
automating the processes of actual selling. The CRM sales applications help
them in understanding and knowing the sales management. Join Frost &
Sullivan and our panel of experts as we explore how sales enablement CRM
tools assist with adherence to formalised sales methodologies, increase
reuse of sales and keep sales personnel where they belong-away from their
desks and out in front of prospective customers.
As one of the world's leading
training providers, we understand how to make training measurable and
deliver lasting results. Our industry-relevant global training solutions
have helped our clients achieve their strategic objectives through their
people for the last 40 years.
Win-win Negotiating
Dates: 15-17 May, 2006
Venue:
London
This three-day programme demonstrates how a successful negotiator can
secure a positive outcome in the negotiation process. It will explore
and explain the differences between typical win-perceived negotiation
and genuine win-win negotiation.
It will serve as a negotiation masterclass for those who negotiate high
value or complex arrangements and for whom better-than-average
negotiating capability is a must.
Key Focus:
Understand how to plan for a negotiation
Assess your individual strengths and weaknesses against a profile of the
ideal negotiator
Learn how to deal with difficult people
Define approaches which have a proven track record for providing effective
control and achieving excellent results
We recognise outstanding
industry achievements by presenting Frost & Sullivan Awards to companies
demonstrating best practices in various regional and global markets.
Award Recipient
•
Kurve Technology Recipient of the
2006 Intranasal Drug Delivery Business Development Strategy
Leadership of the Year Award
Specialty
Pharma - Wedged in Pockets of Risk
Date: 18
May, 2006
Time: 3pm EDT/2pm CDT/8pm BST/9pm CEDT
The Frost & Sullivan
Analyst Briefing series is a 30-minute teleconference and Web cast that
focuses on a specific hot topic in the specialty pharma - wedged in
pockets of risk. The event will provide an overview of the current state
of the market and will discuss technology overviews, industry trends,
key drivers, insights into important trends and opportunities for growth
in the market.
Click
here
to register for
this exclusive analyst briefing.
Do you have an idea or question for our international team of
pharmaceuticals & biotechnology
research analysts?
Simply click
here
to e-mail your enquiry and our analysts will respond with their opinion.
SHARE THE KNOWLEDGE
Do you find this Growth Opportunities Newsletter interesting? If you think
your friend/colleague would be interested in this Newsletter, please reply
with their details below:
Name
Title
E-mail
PERSONAL INFORMATION
The information
we have about you in our files is:
{Name}
{Title}
{Account}
{Address1}
{Address2}
{City}, {State}, {Postalcode}
{Country}
{Workphone}
{Fax}
{E-mail}
Please update this information with changes, if any, by selecting "reply
with history."
RELATED NEWSLETTERS
Click on the links to subscribe to the
respective newsletters.
